Lv3
398 积分 2022-07-16 加入
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial
1个月前
已完结
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
2个月前
已完结
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial
2个月前
已完结
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
2个月前
已完结
Di (2-ethyl hexyl) phthalate (DEHP)-induced kidney injury in quail (Coturnix japonica) via inhibiting HSF1/HSF3-dependent heat shock response
5个月前
已完结
Uridine depletion impairs CD8⁺ T cell antitumor activity through N-glycosylation
6个月前
已完结
A Story of Hypofractionation and the Table on the Wall
10个月前
已完结
Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma
11个月前
已完结
Single-cell transcriptome analysis reveals regulatory programs associated with tumor resistance during immunotherapy in colorectal cancer
11个月前
已完结
Expression Profile of the REG Gene Family in Colorectal Carcinoma
11个月前
已完结
皖公网安备34019202002308
